Kendrion N.v. · EURONEXT:KENDR

Kendrion — Q2 2026 Earnings Presentation

23 slides from Kendrion's earnings presentation, Aug 26, 2026

  1. Slide 1: Q2 and Half Year 2026 results

    AMSTERDAM, 26 AUGUST 2026 Q2 and Half Year 2026 results [Confidential]

  2. Slide 2: Agenda

    Agenda Q2 AND HALF YEAR 2026 RESULTS 1. Key highlights 2. Strategic and operational update 3. Financial review 4. Outlook 5. Q&A [Confidential] 2

  3. Slide 3: Cautionary Note Regarding Forward Looking Statements

    Cautionary Note Regarding Forward Looking Statements Q2 AND HALF YEAR 2026 RESULTS Certain statements contained in this presentation constitute forward-looking statements. These statements may include, without limitation, statements concerning future results of operations, the Company's share of new

  4. Slide 4: 1. Key highlights

    1. Key highlights [Confidential]

  5. Slide 5: Key highlights

    Key highlights Q2 AND HALF YEAR 2026 RESULTS Financial highlights − EBITDA margin of 18.1% in Q2 and 17.5% in HY1, on the upper end of target range − ROI increase to 26.3% (HY1 25: 13.9%) led by good EBITA and strongly reduced capital base − EUR 18.1 million capital returned to shareholders in HY1 a

  6. Slide 6: 2. Strategic and Operational update

    2. Strategic and Operational update 6 [Confidential]

  7. Slide 7: Innovative motion control solutions

    Innovative motion control solutions KENDRION TODAY Transformed pure-play industrial motion control specialist Specialised in actuation, fluid control, braking and control electronics for industrial applications Focused on carefully selected secular growth markets of Robotics & Automation, Healthcare

  8. Slide 8: Strategic pivot to selected growth markets

    Strategic pivot to selected growth markets KENDRION TODAY, FY2025 REVENUE Robotics & Automation ~€120m ~€20m Healthcare & MedTech  Shortage and increasing cost of  Ageing global population manual-intensive labour  Shortage of healthcare expert  Retooling of strategic industries labour  Reshorin

  9. Slide 9: Industrial Actuators and Controls

    Industrial Actuators and Controls Q2 AND HALF YEAR 2026 RESULTS − Revenue in HY1 2026 ended 1% above HY1 2025 − Market demand continues to grow, offset by customer-specific volume decline at a limited number of accounts rather than by underlying market conditions − Order book is healthy - European m

  10. Slide 10: Industrial Actuators and Controls

    Industrial Actuators and Controls LONGER TERM Actuators Inductive Heating − Beverage dispenser valves growing, with more demand in − High number of projects in implementation phase upcoming quarters expected − Low power induction generator SHS* in testing phase at − Automation & robotics market is s

  11. Slide 11: Industrial Brakes

    Industrial Brakes Q2 AND HALF YEAR 2026 RESULTS Revenue growth driven by secular growth in markets of choice − HY1 2026 revenue of EUR 51.5 million: +8% vs HY1 2025 − Growth in automation & robotics and medical − Profitability and cashflow well above prior year − Healthy order book and secular growt

  12. Slide 12: Industrial Brakes

    Industrial Brakes LONG TERM Robotics & Automation − "Perfect Duo" servomotor brake prototypes delivered as platform for Industrial Robots, Cobots and ultimately Humanoids: − Small form factor ‘Slim’ Permanent Magnet Brake − High performance ‘High Torque’ Permanent Magnet Brake − Customised Servo Lin

  13. Slide 13: Strategic Phase-out of Remaining Mobility Activities

    Strategic Phase-out of Remaining Mobility Activities PARTNERSHIP KNORR-BREMSE (KB) − Partnership secures factory continuity as Kendrion volumes decline − Cash flow contribution of partnership of around EUR 7 million Kendrion ownership KB ownership − Continue regular production of FLIP − All producti

  14. Slide 14: Mobility

    Mobility Q2 AND HALF YEAR 2026 RESULTS − Mobility revenues up 4% in 1 HY − Fuel pump controller business runs well − Sound business is below expectation − Good EBITDA development +44 % in HY1 − Cooperation with Knorr-Bremse is running smoothly − Cooperation agreement support continued positive cash

  15. Slide 15: 2. Financial review

    2. Financial review [Confidential]

  16. Slide 16: Business review

    Business review Q2 AND HALF YEAR RESULTS Q2 2026 Q2 2025 Q2 2026 highlights Normalized (in EUR million) delta Revenue 63,6 61,4 4% EBITDA 11,5 9,9 16% EBITA 8,4 6,6 27% − Revenue growth led by Automation & Robotics segment Net profit before amortization from continuing operations 5,9 4,3 37% Net pro

  17. Slide 17: Business review

    Business review DEVELOPMENT BY SEGMENT Industrial − HY1 2026 revenue increase by 5% driven by IAC -/-2% IAC +1% IB + 8% IB +8% improved market conditions and pipeline MOB + 8% MOB + 4% conversion to revenue − IB increases 8% with strong demand in Automation and medical − IAC growth of 1% with good m

  18. Slide 18: Business review

    Business review CASH FLOW AND FINANCIAL POSITION Highlights − Normalized free cash flow of EUR 4.0 million in HY1, affected by seasonal build up of working capital in HY1 − Dividend payment and share repurchase program drive net debt increase of EUR 17.8 million − Solid financial position with lever

  19. Slide 19: 3. Outlook

    3. Outlook [Confidential]

  20. Slide 20: Outlook

    Outlook… − Macroeconomic visibility remains limited as geopolitical and trade uncertainty persists − For the second half, Kendrion expects the strong performance to continue supported by a healthy order book, and strong project pipeline − As industrial systems become smarter and more autonomous, the

  21. Slide 21: 2027 Financial Targets

    2027 Financial Targets UNCHANGED HY1 2026 Expectation: 5-8% annual Revenue growth (2024-2027) 5%* EBITDA margin 15%-18% from 2025 17.5% ROI** 23%-27% from 2027 26.3% At least 50% of Dividend Normalized Net Profit 61% * Against HY1 2025 in constant currency ** EBITA / invested capital, excluding good

  22. Slide 22: Capital Markets Day – Key Topics

    Capital Markets Day – Key Topics 17 SEPTEMBER 2026 01 Kendrion strategy: Focused Industrial Specialist in Motion Control 02 Markets of choice: Key Applications Segments and Secular Growth opportunities 03 Technology: Mission Critical and Performance Enhancing 04 Commercial traction: Key Customers an

  23. Slide 23: 4. Q&A

    4. Q&A [Confidential]

Kendrion — Q2 2026 Earnings Presentation on 6ix